Mike has a 25 year history of founding and leading start-up companies in the medical field.
He has a PhD in biochemistry from the University of Leeds. In addition to his business experience he has maintained a rigorous academic reputation, with numerous publications in the fields of arthritis and medical imaging. He has been involved in the development of several novel biomarkers in osteo- and rheumatoid arthritis, and the validation of existing biomarkers in several areas of 3D medical imaging. He speaks regularly on the measurement and identification of disease in osteoarthritis and rheumatoid arthritis, image-guided surgery and automated 3D segmentation.